Decision Resources acquires Manhattan Research

Share this article:

Decision Resources announced the acquisition of Manhattan Research on June 17.  The move will expand Decision Resources' global physician and consumer digital market research portfolio, according to a statement.  Terms of the deal were not disclosed to the public.

“Part of Decision Resources' big goal is to grow our business both organically, and to build a stable of premier market research firms that focus on specific areas of the healthcare industry,” said Elizabeth Marshall, director of marketing at Decision Resources.  Marshall cites Millennium Research Group and HealthLeaders as two examples of other research firms providing Decision Resources with a specialized focus: Millennium for medical devices and technology, and HealthLeaders for managed care.  “We're looking at the bigger picture and the healthcare industry as a whole – we're offering clients an integrated model,” says Marshall.  

Manhattan Research will remain headquartered in New York, NY.  Decision Resources is located in Waltham, MA.  Other companies owned by Decision Resources include Arlington Medical Resources, which was acquired last December, and Fingertip Formulary, acquired in March. 

Share this article:

Email Newsletters

More in News

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...

Bayer drug gets orphan label

Bayer drug gets orphan label

The FDA designation is for an experimental, inhaled form of ciprofloxacin intended to treat a rare lung condition.

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.